Table 4 Clinicopathological features of these 200 sporadic lung cancer tissues
From: Identification and validation of PROM1 and CRTC2 mutations in lung cancer patients
| Â | Lung cancer |
|---|---|
Characteristics | N(%) |
Age in years: median | 57.93 ± 10.480 |
Gender | Â |
  Female | 56(28.00) |
  Male | 144(72.00) |
Smoking status | Â |
  Never | 92(46.00) |
  Ever | 108(54.00) |
Pack years (median, range) | 741.94(10–3000) |
Histological type | Â |
  adenocarcinoma | 95(47.50) |
  squamous cell carcinoma | 93(46.50) |
  adenosquamous carcinoma | 10(5.00) |
  others | 2(1.00)a |
Clinical stageb | Â |
  I | 54(27.27) |
  II | 56(28.28) |
  III | 70(35.35) |
  IV | 18(9.10) |
Tumor differentiationb | Â |
  Poor | 92(46.47) |
  Moderate and poor-moderate | 100(50.51) |
  Well and moderate-well | 6(3.02) |
Lymph node metastasis | Â |
  Negative | 98(49.00) |
  Positive | 102(51.00) |